ImmunityBio Inc

{ "date": [ "202612", "202712", "202812", "202912", "203012" ], "revenue_estimate": [ 222.33, 452.03, 1406.5, 2291.9, 3116.5 ], "ebit_estimate": [ -249.6, -109.87, 626, 1328.9, 1954.3 ], "ebitda_estimate": [ null, null, null, null, null ], "net_income_estimate": [ -880.77, -168.4, 565.5, 1002.1, 1496.1 ], "per_share_eps_estimate": [ -0.85, -0.16, 0.54, 0.95, 1.41 ], "eps_nri_estimate": [ -0.85, -0.16, 0.54, 0.95, 1.41 ], "dividend_estimate": [ null, null, null, null, null ], "book_value_per_share_estimate": [ null, null, null, null, null ], "pretax_income_estimate": [ -880.78, -168.38, 565.5, 1268.4, 1893.8 ], "operating_cash_flow_per_share_estimate": [ null, null, null, null, null ], "roa_estimate": [ null, null, null, null, null ], "roe_estimate": [ null, null, null, null, null ], "gross_margin_estimate": [ 98.3, 94.5, 83, 83, null ], "operating_cash_flow_estimate": [ null, null, null, null, null ], "pettm_estimate": [ 0, 0, 15.24, 8.66, 5.84 ], "long_term_growth_rate_mean": 0, "long_term_revenue_growth_rate_mean": "128.56", "future_per_share_eps_estimate_growth": null, "future_eps_nri_estimate_growth": null, "future_revenue_estimate_growth": 128.56, "future_ebit_estimate_growth": null, "future_ebitda_estimate_growth": null, "future_dividend_estimate_growth": null, "future_net_income_estimate_growth": null, "future_pretax_income_estimate_growth": null, "future_book_value_per_share_estimate_growth": null, "future_roa_estimate_growth": null, "future_roe_estimate_growth": null, "future_gross_margin_estimate_growth": -5.62, "future_operating_cash_flow_per_share_estimate_growth": null }

{ "date": [ "202606", "202609", "202612", "202703", "202706", "202709", "202712" ], "revenue_estimate": [ 49.2, 57.65, 71.28, 60.8, 66, 71.3, 85.1 ], "ebit_estimate": [ -67.04, -61.31, -51.42, -60.65, -62.25, -57.95, -51.74 ], "ebitda_estimate": [ null, null, null, null, null, null, null ], "net_income_estimate": [ -90.05, -84.7, -75.18, -90.8, -92.95, -89.2, -84.04 ], "per_share_eps_estimate": [ -0.09, -0.08, -0.07, -0.09, -0.09, -0.08, -0.08 ], "eps_nri_estimate": [ -0.09, -0.08, -0.07, -0.09, -0.09, -0.08, -0.08 ], "dividend_estimate": [ null, null, null, null, null, null, null ], "book_value_per_share_estimate": [ null, null, null, null, null, null, null ], "pretax_income_estimate": [ -90.04, -84.69, -75.18, -90.8, -92.95, -89.2, -84.04 ], "operating_cash_flow_per_share_estimate": [ null, null, null, null, null, null, null ], "roa_estimate": [ null, null, null, null, null, null, null ], "roe_estimate": [ null, null, null, null, null, null, null ], "gross_margin_estimate": [ 99, 98, 97, 96, 95.1, 94.1, 93.2 ], "operating_cash_flow_estimate": [ null, null, null, null, null, null, null ], "pettm_estimate": [ 0, 0, 0, 0, null, null, null ], "long_term_growth_rate_mean": 0, "long_term_revenue_growth_rate_mean": "128.56", "future_per_share_eps_estimate_growth": null, "future_eps_nri_estimate_growth": null, "future_revenue_estimate_growth": 128.56, "future_ebit_estimate_growth": null, "future_ebitda_estimate_growth": null, "future_dividend_estimate_growth": null, "future_net_income_estimate_growth": null, "future_pretax_income_estimate_growth": null, "future_book_value_per_share_estimate_growth": null, "future_roa_estimate_growth": null, "future_roe_estimate_growth": null, "future_gross_margin_estimate_growth": -5.62, "future_operating_cash_flow_per_share_estimate_growth": null }